Efficacy and safety of high-dose etoposide cytarabine as consolidation following rituximab methotrexate temozolomide induction in newly diagnosed primary central nervous system lymphoma in immunocompetent patients

Haematologica. 2018 Jul;103(7):e296-e299. doi: 10.3324/haematol.2017.185843. Epub 2018 Feb 22.

Rudy Birsen^{1

2}, Lise Willems^{1

2}, Johan Pallud^{1

3}, Estelle Blanc⁴, Barbara Burroni^{1

5}, Marielle Legoff^{1

2}, Emmanuelle Le Ray^{1

2}, Sylvain Pilorge², Benedicte Deau^{1

2}, Patricia Franchi^{1

2}, Marguerite Vignon^{1

2}, Yioula Kirova⁶, Myriam Edjlali^{1

7}, Caroline Houillier⁸, Carole Soussain⁹, Pascale Varlet¹⁰, Edouard Dezamis^{1

3}, Diane Damotte^{1

5}, Didier Bouscary^{1

2}, Jerome Tamburini^{11

2}

¹ Paris Descartes University, Sorbonne Paris Cité, France.
² Hematology Department, Cochin Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP), France.
³ Department of Neurosurgery, Sainte-Anne Hospital, Paris, France.
⁴ Nuclear Medicine, Marie Lannelongue Hospital, Plessis Robinson, France.
⁵ Pathology Department, Cochin Hospital, AP-HP, Paris, France.
⁶ Radiotherapy Department, Curie Institute, Paris, France.
⁷ Department of NeuroImaging, Sainte-Anne Hospital, Paris, France.
⁸ Service de Neurologie 2-Mazarin, Groupe Hospitalier Pitié-Salpêtrière, AP-HP, Sorbonne Universités UPMC Universités Paris VI, IHU, ICM, France.
⁹ Hematology Department, Curie Institute, Saint Cloud, France.
¹⁰ Pathology Department, Sainte-Anne Hospital, Paris, France.
¹¹ Paris Descartes University, Sorbonne Paris Cité, France jerome.tamburini@aphp.fr.

No abstract available

Publication types